International Journal of Endocrinology / 2017 / Article / Tab 3

Research Article

Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes

Table 3

Adverse events in the exenatide and metformin groups.

Adverse eventsExenatide ()Metformin ()

Major hypoglycemia, n (%)001
Minor hypoglycemia, n (%)5 (4.7%)3 (2.5%)0.481